HCA Healthcare (NYSE:HCA) was downgraded by investment analysts at Bank of America from a “neutral” rating to an “underperform” rating in a note issued to investors on Thursday. They currently have a $90.00 target price on the stock, down from their previous target price of $94.00. Bank of America’s price target would suggest a potential upside of 3.53% from the company’s previous close.
HCA has been the subject of several other research reports. Credit Suisse Group restated an “outperform” rating and set a $25.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 26th. Robert W. Baird restated a “buy” rating on shares of HCA Healthcare in a report on Thursday, September 28th. Raymond James Financial downgraded HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, October 18th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price on the stock. in a research report on Wednesday, December 20th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $92.00 target price on shares of HCA Healthcare in a research report on Wednesday, October 4th. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $87.60.
HCA Healthcare (NYSE HCA) traded up $0.97 during midday trading on Thursday, hitting $86.93. The stock had a trading volume of 3,073,451 shares, compared to its average volume of 2,053,903. The company has a market capitalization of $30,777.83, a P/E ratio of 12.37, a price-to-earnings-growth ratio of 1.17 and a beta of 0.55. HCA Healthcare has a 52-week low of $71.18 and a 52-week high of $91.03. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68.
In other HCA Healthcare news, SVP Victor L. Campbell sold 8,000 shares of the business’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total value of $624,000.00. Following the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at $9,927,450. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the transaction, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The disclosure for this sale can be found here. In the last three months, insiders sold 22,700 shares of company stock worth $1,773,872. Insiders own 2.90% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Strs Ohio lifted its position in shares of HCA Healthcare by 12.2% during the 3rd quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock valued at $85,621,000 after buying an additional 117,000 shares during the last quarter. AustralianSuper Pty Ltd purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at $24,410,000. Yellowstone Partners LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at $5,802,000. Toronto Dominion Bank lifted its position in shares of HCA Healthcare by 12.8% during the 3rd quarter. Toronto Dominion Bank now owns 112,657 shares of the company’s stock valued at $8,965,000 after buying an additional 12,744 shares during the last quarter. Finally, Micawber Capital LLC lifted its position in shares of HCA Healthcare by 31.3% during the 3rd quarter. Micawber Capital LLC now owns 34,461 shares of the company’s stock valued at $2,743,000 after buying an additional 8,205 shares during the last quarter. 75.34% of the stock is currently owned by institutional investors and hedge funds.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
